5-12% for males and 10-25% for females have a lifetime prevalence of major depressive episode. First line treatment for depression is selective serotonin reuptake inhibitors (SSRIs) these have limite d side effects.
5-12% for males and 10-25% for females have a lifetime prevalence of major depressive episode. First line treatment for depression is selective serotonin reuptake inhibitors (SSRIs) these have limite d side effects.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as TXT, PDF, TXT or read online from Scribd
5-12% for males and 10-25% for females have a lifetime prevalence of major depressive episode. First line treatment for depression is selective serotonin reuptake inhibitors (SSRIs) these have limite d side effects.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as TXT, PDF, TXT or read online from Scribd
Q.major variables to consider for depressive disorders?
A. energy, sleep, concentration, mood, appetite .
Q.Lifetime prevalence of major depressive episode is what in males and females? A. 5-12% for males and 10-25% for females. Q.definition of Recurrent major depressive disorder? A. It requires 2 or more episodes with a symptom-free interval of 2 months. Q.describe Dysthymia? A. it is a milder form of depression lasting at least 2 years. Q.what is the First line treatment for depression ? A. it's selective serotonin reuptake inhibitors (SSRIs) because they have limite d side effects. Q.Major adverse effects of ECT? A. these are disorientation, anterograde amnesia, and retrograde amnesia.